Sandoz Group AG Sandoz Group AG

Sandoz Group AG

SDZ

Rangering i aksjer #579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Aksjekurs
$95.99
Markedsverdi
$41.53B
Endring (1 dag)
0.79%
Endring (1 år)
58.61%
Land
CH
Handel Sandoz Group AG (SDZ)

Kategori

Healthcare
Historikk for aksjesplitt for Sandoz Group AG (SDZ)
Aksjen Sandoz Group AG (symbol: SDZ) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én SDZ-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 SDZ-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter